Celebrating 20 years of innovation - Discover how we've been a catalyst for regional growth and UK innovation for over two decades in CPI's Annual Review 2023-2024.
One in five UK HealthTech SMEs head to US for product launch
Up to 24% of UK-based HealthTech SMEs launch their innovations in the US, rather than the UK, due to its market size and favourable regulatory environment.
Jan 11 2023
NeoVac and CPI partner to accelerate next-generation RNA vaccine technology to clinical trials
We’re helping NeoVac fast-track its lipid nanoparticle technology to clinical trials, to make RNA products more transportable, and have fewer side effects.
Dec 13 2022
Fabrication laboratory to advance customised FMCG installed at CPI
DIY4U announces the successful installation of a fabrication laboratory at CPI, bringing us closer to customised fast-moving consumer goods.
Dec 08 2022
CPI opens world-leading Medicines Manufacturing Innovation Centre in Scotland to raise the bar in pharma manufacturing
Our Medicines Manufacturing Innovation Centre opens in Glasgow, with leading digital transformation provider Atos the latest to join the partnership.
Nov 30 2022
CPI invests in BiologIC Technologies to advance next-generation bioprocess innovation
We have invested in BiologIC Technologies (BiologIC), our seventh CPI Enterprises investment to date.
Nov 29 2022
High Value Manufacturing Catapult signs MoU with Greater Manchester to provide £1.7 billion manufacturing boost
The HVM Catapult joins forces with Innovation Greater Manchester and Greater Manchester Combined Authority to drive industrial transformation.
Nov 16 2022
Supporting innovation and growth through the UK Community Renewal Fund
With funding from the UK Community Renewal Fund via the Northeast LEP, we’ve enabled two battery businesses to move to the region, with one investing £3m.
Oct 31 2022
Founder of Investing Women Angels and AccelerateHER joins CPI Board
Jackie Waring joins our Board as Non-Executive Director, making her the fifth new Board member in 2022.
Oct 11 2022
Our new RNA Centre of Excellence and RNA Training Academy are set to open
Funded by £10.65 million from the UK Government’s Vaccine Taskforce to support the development, scale-up, and manufacture of RNA vaccines and therapies.
